Background: Cardiovascular disease caused by atherosclerosis is responsible for 18 million deaths annually, highlighting a significant need for new medical therapies, especially for patients who are ...

View all available purchase options and get full access to this article.

View all available purchase options and get full access to this article.

View all available purchase options and get full access to this article.

The 2025 AHA/ACC High Blood Pressure Guideline reflects the latest recommendations and advancements in hypertension research and clinical practice. This curated collection of commentaries and ...

View all available purchase options and get full access to this article.

Abstracts from the American Stroke Association's 2025 International Stroke Conference and State-of-the-Science Stroke Nursing Symposium 2025 ...

Drug-induced cardiotoxicity (DICT) is a severe adverse drug reaction that affects the cardiovascular system and is a leading cause of drug withdrawals and clinical trial failures. 1 DICT prediction is ...

The clinical syndrome of heart failure (HF), encompassing a constellation of signs and symptoms, has been recognized for more than a century. The incremental steps over the past 100 years—discoveries ...

Chronic coronary disease (CCD) affects millions of people worldwide and is responsible for significant morbidity, mortality, and costs. CCD as defined in the 2023 guideline 1 includes patients who may ...

Introduction: Cuffless blood pressure (BP) monitors are a promising innovation for hypertension diagnosis and monitoring. Aktiia (Aktiia 24/7 BP Monitor, Aktiia, Switzerland) is a CE-marked, ...

Since the last published CPG for heart failure (HF), the field has progressed rapidly with much new evidence. As such, the authors of the new ACCF/AHA/HFSA and ESC guidelines had a monumental task of ...